Article
Laleh Amiri-Kordestani & Richard Pazdur
Life After Medical Affairs: From MSL to M & A
Summary
In this episode, Steve St. Onge shares his unique journey from traditional MSL roles to business development at Paratek. He discusses his background, transition to industry, and involvement in nontraditional MSL work. Steve delves into the challenges faced during his shift to business development and highlights essential skills for success in this area. The conversation also touches on overcoming the glass ceiling in medical affairs and leveraging medical affairs expertise in business roles. Steve offers valuable advice for MSLs considering a move into M&A or business development, emphasizing the importance of company research and utilizing LinkedIn for career advancement.
This episode features Steve St. Onge, Sr Director Business Development at Paratek discusses his career path from Medical Affairs to Business Development (M and A) and how he got there
We discuss….
👉 How he transitioned from Medical Affairs to M and A
👉 What his role in Business Development and M and A entails
👉 The difference between Corporate Development and Business Development
👉 Why LinkedIn can be an MSLs worst enemy
👉 The “glass ceiling” in Medical Affairs
👉 Why you need to learn the DNA of a company
St. Onge, MSL to Business Development, Paratek career transition, overcoming glass ceiling in medical affairs, LinkedIn for career advancement
Related Topics
You May Also Like
Laleh Amiri-Kordestani & Richard Pazdur
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
Podcast
The Oncology Nursing Podcast